| Sensitive detection of mono-and polyclonal ESR1 mutations in primary tumors, metastatic lesions, and cell-free DNA of breast cancer patients P Wang, A Bahreini, R Gyanchandani, PC Lucas, RJ Hartmaier, ... Clinical cancer research 22 (5), 1130-1137, 2016 | 226 | 2016 |
| Circulating tumor cell phenotyping via high‐throughput acoustic separation M Wu, PH Huang, R Zhang, Z Mao, C Chen, G Kemeny, P Li, AV Lee, ... Small 14 (32), 1801131, 2018 | 183 | 2018 |
| Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck A Argiris, AP Kotsakis, T Hoang, FP Worden, P Savvides, MK Gibson, ... Annals of oncology 24 (1), 220-225, 2013 | 168 | 2013 |
| Intratumor heterogeneity affects gene expression profile test prognostic risk stratification in early breast cancer R Gyanchandani, Y Lin, HM Lin, K Cooper, DP Normolle, A Brufsky, ... Clinical Cancer Research 22 (21), 5362-5369, 2016 | 88 | 2016 |
| A proangiogenic signature is revealed in FGF-mediated bevacizumab-resistant head and neck squamous cell carcinoma R Gyanchandani, MV Ortega Alves, JN Myers, S Kim Molecular Cancer Research 11 (12), 1585-1596, 2013 | 77 | 2013 |
| Detection of ESR1 mutations in circulating cell-free DNA from patients with metastatic breast cancer treated with palbociclib and letrozole R Gyanchandani, KJ Kota, AR Jonnalagadda, T Minteer, BA Knapick, ... Oncotarget 8 (40), 66901, 2016 | 46 | 2016 |
| Interleukin-8 as a modulator of response to bevacizumab in preclinical models of head and neck squamous cell carcinoma R Gyanchandani, D Sano, MVO Alves, JD Klein, BA Knapick, S Oh, ... Oral oncology 49 (8), 761-770, 2013 | 33 | 2013 |
| Targeted mutation detection in breast cancer using MammaSeq™ NG Smith, R Gyanchandani, OS Shah, GT Gurda, PC Lucas, ... Breast Cancer Research 21, 1-11, 2019 | 32 | 2019 |
| Pointwise mutual information quantifies intratumor heterogeneity in tissue sections labeled with multiple fluorescent biomarkers DM Spagnolo, R Gyanchandani, Y Al-Kofahi, AM Stern, TR Lezon, ... Journal of pathology informatics 7 (1), 47, 2016 | 29 | 2016 |
| Whole genome amplification of cell-free DNA enables detection of circulating tumor DNA mutations from fingerstick capillary blood R Gyanchandani, E Kvam, R Heller, E Finehout, N Smith, K Kota, ... Scientific reports 8 (1), 17313, 2018 | 24 | 2018 |
| Predictive biomarkers to anti-VEGF therapy: progress toward an elusive goal R Gyanchandani, S Kim Clinical Cancer Research 19 (4), 755-757, 2013 | 8 | 2013 |
| Intratumor heterogeneity: Biological and clinical implications R Gyanchandani, N Priedigkeit, A Basudan, AV Lee Oncogenomics, 17-30, 2019 | 3 | 2019 |
| Tumor Cell Phenotyping: Circulating Tumor Cell Phenotyping via High‐Throughput Acoustic Separation (Small 32/2018) M Wu, PH Huang, R Zhang, Z Mao, C Chen, G Kemeny, P Li, AV Lee, ... Small 14 (32), 1870145, 2018 | 1 | 2018 |
| Detection and functional analysis of estrogen receptor mutations (ESR1-mut) in patients with metastatic breast cancer (MBC). S Puhalla, P Wang, A Bahreini, R Gyanchandani, TF Ambros, ... Journal of Clinical Oncology 33 (15_suppl), 554-554, 2015 | 1 | 2015 |
| Targeted Mutation Detection in Advanced Breast Cancer Using MammaSeq Identifies RET as a Potential Contributor to Breast Cancer Metastasis N Smith, R Gyanchandani, N Priedigkeit, RJ Hartmaier, Y Chen, G Gurda, ... University of Pittsburgh, 2018 | | 2018 |
| Polyploid tumor cells: a chemoresistant cell type in triple-negative breast cancer R Gyanchandani, A Lee Cancer Research 77 (13_Supplement), 2050-2050, 2017 | | 2017 |
| cfDNA mutation frequency in early stage breast cancer. KJ Kota, R Gyanchandani, MQ Rosenzweig, A Brufsky, ... Journal of Clinical Oncology 35 (15_suppl), e23047-e23047, 2017 | | 2017 |
| Abstract P6-07-07: ESR1 amplification and 5'-3'exon imbalance in metastatic breast cancer S Oesterreich, A Basudan, N Preideigkeit, RJ Hartmaier, A Bahreini, ... Cancer Research 77 (4_Supplement), P6-07-07-P6-07-07, 2017 | | 2017 |
| Palbociclib's effect on estrogen receptor mutations in metastatic breast cancer. KJ Kota, R Gyanchandani, A Brufsky, AV Lee, S Oesterreich, S Puhalla Journal of Clinical Oncology 34 (15_suppl), 533-533, 2016 | | 2016 |
| Abstract B48: Intratumor ploidy heterogeneity as a chemoresistance mechanism in triple-negative breastcancer R Gyanchandani, A Lee Molecular Cancer Research 14 (2_Supplement), B48-B48, 2016 | | 2016 |
